Downregulation of miRNA-128 sensitises breast cancer cell to chemodrugs by targeting Bax

Mechanism of Cell Adaptation

(2011) Valentina Fodale et al.   CANCER JOURNAL

Bax dimerizes via a symmetric BH3:groove interface during apoptosis

(2011) G Dewson et al.   CELL DEATH AND DIFFERENTIATION

Reduced miR-128 in Breast Tumor-Initiating Cells Induces Chemotherapeutic Resistance via Bmi-1 and ABCC5

(2011) Y. Zhu et al.   CLINICAL CANCER RESEARCH

Genetic determinants of anticancer drug activity: towards a global approach to personalized cancer medicine

(2011) Alexander Picker et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

A specific miRNA signature in the peripheral blood of glioblastoma patients

(2011) Patrick Roth et al.   JOURNAL OF NEUROCHEMISTRY

MicroRNA and Target Protein Patterns Reveal Physiopathological Features of Glioma Subtypes

(2011) Elodie Lages et al.   PLoS One

Overexpression of miR-128 specifically inhibits the truncated isoform of NTRK3 and upregulates BCL2 in SH-SY5Y neuroblastoma cells

(2010) Monica Guidi et al.   BMC MOLECULAR BIOLOGY

Primary systemic chemotherapy of breast cancer: indication and predictive factors

(2010) Hiromitsu Jinno et al.   Breast Cancer